References

  1. Legler TJ et al. RHD genotyping in weak D phenotypes by multiple polymerase chain reactions. Transfusion, 1998. [Citation] [RHeference]
  2. Legler TJ et al. D(Va) category phenotype and genotype in Japanese families. Vox Sang, 2000. [Citation] [RHeference]
  3. Legler TJ et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med, 2001. [Citation] [RHeference]
  4. Shao CP et al. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang, 2002. [Citation] [RHeference]
  5. Perco P et al. Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type. Transfusion, 2003. [Citation] [RHeference]
  6. Körmöczi GF et al. Molecular and serologic characterization of DWI, a novel "high-grade" partial D. Transfusion, 2004. [Citation] [RHeference]
  7. Wagner T et al. Anti-D immunization by DEL red blood cells. Transfusion, 2005. [Citation] [RHeference]
  8. Körmöczi GF et al. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion, 2005. [Citation] [RHeference]
  9. Gassner C et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion, 2005. [Citation] [RHeference]
  10. Müller SP et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion, 2008. [Citation] [RHeference]
  11. Gardener GJ et al. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion, 2012. [Citation] [RHeference]
  12. Van Sandt VS et al. RHD variants in Flanders, Belgium. Transfusion, 2015. [Citation] [RHeference]